Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

Authors: Pietro Lampertico, Marı́a Buti, Scott Fung, Sang Hoon Ahn, Wan‐Long Chuang, Won Young Tak, Alnoor Ramji, Chi-Yi Chen, Edward Tam, Ho Bae, Xiaoli Ma, John F. Flaherty, Anuj Gaggar, Audrey Lau, Yang Liu, George Y. Wu, Vithika Suri, Susanna K. Tan, G. Mani Subramanian, Huy N. Trinh, Seung Kew Yoon, Kosh Agarwal, Young‐Suk Lim, Henry Lik‐Yuen Chan - The Lancet 2020 cited by 139